Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Laronidase for Cognitive Decline in MPS I
NCT00852358Phase 2Completed
- Start
- Jun 2009
- Primary completion
- Apr 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of laronidase in mucopolysaccharidosis type I. Started Jun 2009; status: completed.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on NCT00852358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852358.